A Study of LY3372993 in Participants With Alzheimer's Disease (AD) and Healthy Participants

NCT04451408 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

139

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease
Healthy

Interventions

DRUG: LY3372993
DRUG: Placebo

Sponsor

Eli Lilly and Company